Medical device giant Medtronic was hit with three lawsuits in the District of Delaware on Nov. 12—two by the previous ...

Read the Market Summary Here @- Global Bowel Management Systems Market Size Expands at Healthy CAGR of 4.98% to Touch USD 3.24 Billion by 2030 Global Bowel Management Systems Market is expanding ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

The "Bowel Management Systems - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The bowel management systems market was valued at ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density (HD) mapping and ...

Indian Para-athlete and Disability Rights Activist Suvarna Raj Wins Prestigious United Nations SDG Action Award in Rome, Italy ...

Axonics had a negative return on equity of 0.27% and a negative net margin of 0.42%. The firm’s quarterly revenue was up 23.3% on a year-over-year basis. During the same period last year, the ...

This page features the latest news about the Axonics Modulation Technologies stock. Axonics stock soars to 52-week high, reaches $69.92 Axonics Modulation Technologies Inc. (NASDAQ:AXNX ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

Piper Sandler analyst Matthew O’Brien maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $90.00. The company’s shares closed yesterday at $90.99.